Cargando…
Phospho-Ser(784)-VCP Drives Resistance of Pancreatic Ductal Adenocarcinoma to Genotoxic Chemotherapies and Predicts the Chemo-Sensitizing Effect of VCP Inhibitor
SIMPLE SUMMARY: Defining the mechanisms underlying the heterogeneous cancer cell response to DNA damage is important for our ability to tailor individualized strategies to improve chemotherapy efficacy. In this study, we focus on a central DNA repair regulator named VCP whose loss-of-function has be...
Autores principales: | Wang, Faliang, Vij, Kiran, Li, Lin, Dodhiawala, Paarth, Lim, Kian-Huat, Shao, Jieya |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8534018/ https://www.ncbi.nlm.nih.gov/pubmed/34680224 http://dx.doi.org/10.3390/cancers13205076 |
Ejemplares similares
-
Phospho-Ser(784)-VCP Is Required for DNA Damage Response and Is Associated with Poor Prognosis of Chemotherapy-Treated Breast Cancer
por: Zhu, Cuige, et al.
Publicado: (2020) -
Ser(784) phosphorylation: a clinically relevant enhancer of VCP function in the DNA damage response
por: Shao, Jieya
Publicado: (2020) -
Valosin-containing protein (VCP) is required for autophagy and is disrupted in VCP disease
por: Ju, Jeong-Sun, et al.
Publicado: (2009) -
Heterozygous mutations in valosin-containing protein (VCP) and resistance to VCP inhibitors
por: Bastola, Prabhakar, et al.
Publicado: (2019) -
Co-selected mutations in VCP: a novel mechanism of resistance to VCP inhibitors
por: Bastola, Prabhakar, et al.
Publicado: (2018)